摘要
目的 :观察低分子肝素钙治疗缺血性脑血管病的疗效。方法 :缺血性脑血管病患者 2 9例 ,将 410 0U低分子肝素钙溶于 0 .4mL 0 .9%氯化钠注射液中皮下注射 ,每次注射持续 10～ 15s ,q 12h ,疗程 10d。结果 :显著进步 7例(2 4.1%) ,进步 17例 (5 8.6%) ,总有效率 82 .7%。在治疗过程中不良反应少。结论
Objective:To observe the effect of Fraxiparine in treatment of ischcmic cerebrovascular disease. Methods:We treated and observed 29 cases of cerebral infarction who were confirmed by craniocerebral CT scan and with a onset within 72 hours. All the patients were evaluated using 'Clinical neurologic deficit assessment for stroke'. Results:Fraxiparine had significant effect in treating ischemic cerebrovascular disease. 7 case (24.1%)of cerebral infarction relieved greatly, and 17 cases (58.6%)improved. The overall effective rate accounted for 82.7%. The side effect was mild. Conclusion:These results suggested that fraxiparine is an effective and safe agent for the treatment of ischemic cerebrovascula disease.
出处
《医药导报》
CAS
2002年第7期426-427,共2页
Herald of Medicine
